FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2020366043> ?p ?o ?g. }

• W2020366043 endingPage "A7" @default.
• W2020366043 startingPage "A7" @default.
• W2020366043 abstract "A survey of a series of genetic centers in Europe [1] showed that today a substantial number of samples from patients are being sent abroad for DNA analysis to laboratories in Europe, the US or elsewhere in the world. 66% of the 233 laboratories, which replied to the questionnaire, received samples from other countries and 47% sent samples to other countries. In absolute numbers this would mean that about 1⁄4 of all samples cross borders today. This traffic will only further increase when the European cross-border directive 2011/24 [2] will be activated. This directive states that “Member States shall bring into force the laws, regulations and administrative provisions necessary to comply with this Directive by 25 October 2013”. The focus of these regulations and provisions should be on the quality of the services wherever the patients or their samples are being examined [3]. The quality management of the facilities i.e. evidence that they follow international guidelines, e.g. those published in 2007 by the OECD [4] or are accredited under the ISO 15189; that appropriate preand posttesting counseling is guaranteed, particularly when whole genome or exome sequencing is considered; and that patient representatives are involved in the implementation of these processes, should become compulsory. The Direct to Consumer (DTC) testing facilities, available through internet, have forced geneticists to reconsider the way genetic services are provided. A positive aspect of this development is that issues, such as information for prospective consumers, counseling and support, consent, data protection, interpretation of results, and others have received much more attention than in the past. The EuroGentest Network of Excellence (NoE), supported by DG Research (2005 – 2010)and its successor as Coordination Action (2011-2013), together with the European Society of Human Genetics, have worked very hard on the improvement of the quality of the genetic services in Europe. Nevertheless, such efforts by ‘volunteers’, will not suffice once the new Directive is in place. To guarantee quality services to the consumers we will need harmonisation of the services, which can only be achieved at the European level through the existing facilities of the commission. There is a need for a regulatory framework for Quality Assurance (ISO accreditation), for test development and use, harmonised legal, regulatory and healthcare policies for pharmacogenetics as well as a the finalization of the revision of the IVD directive, preferably in harmony with the ‘Global Health Task Force’." @default.
• W2020366043 created "2016-06-24" @default.
• W2020366043 creator A5044371953 @default.
• W2020366043 date "2012-01-01" @default.
• W2020366043 modified "2023-09-26" @default.
• W2020366043 title "Can the cross-borders directive improve the quality of genetic testing in the future?" @default.
• W2020366043 cites W2095487434 @default.
• W2020366043 doi "https://doi.org/10.1186/1750-1172-7-s2-a7" @default.
• W2020366043 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3504584" @default.
• W2020366043 hasPublicationYear "2012" @default.
• W2020366043 type Work @default.
• W2020366043 sameAs 2020366043 @default.
• W2020366043 citedByCount "0" @default.
• W2020366043 crossrefType "journal-article" @default.
• W2020366043 hasAuthorship W2020366043A5044371953 @default.
• W2020366043 hasBestOaLocation W20203660431 @default.
• W2020366043 hasConcept C104317684 @default.
• W2020366043 hasConcept C111472728 @default.
• W2020366043 hasConcept C138885662 @default.
• W2020366043 hasConcept C144133560 @default.
• W2020366043 hasConcept C199360897 @default.
• W2020366043 hasConcept C2779530757 @default.
• W2020366043 hasConcept C2779547435 @default.
• W2020366043 hasConcept C2780673598 @default.
• W2020366043 hasConcept C41008148 @default.
• W2020366043 hasConcept C47042493 @default.
• W2020366043 hasConcept C54355233 @default.
• W2020366043 hasConcept C86803240 @default.
• W2020366043 hasConceptScore W2020366043C104317684 @default.
• W2020366043 hasConceptScore W2020366043C111472728 @default.
• W2020366043 hasConceptScore W2020366043C138885662 @default.
• W2020366043 hasConceptScore W2020366043C144133560 @default.
• W2020366043 hasConceptScore W2020366043C199360897 @default.
• W2020366043 hasConceptScore W2020366043C2779530757 @default.
• W2020366043 hasConceptScore W2020366043C2779547435 @default.
• W2020366043 hasConceptScore W2020366043C2780673598 @default.
• W2020366043 hasConceptScore W2020366043C41008148 @default.
• W2020366043 hasConceptScore W2020366043C47042493 @default.
• W2020366043 hasConceptScore W2020366043C54355233 @default.
• W2020366043 hasConceptScore W2020366043C86803240 @default.
• W2020366043 hasIssue "Suppl 2" @default.
• W2020366043 hasLocation W20203660431 @default.
• W2020366043 hasLocation W20203660432 @default.
• W2020366043 hasLocation W20203660433 @default.
• W2020366043 hasOpenAccess W2020366043 @default.
• W2020366043 hasPrimaryLocation W20203660431 @default.
• W2020366043 hasRelatedWork W1500481867 @default.
• W2020366043 hasRelatedWork W1963853912 @default.
• W2020366043 hasRelatedWork W1964496002 @default.
• W2020366043 hasRelatedWork W2020366043 @default.
• W2020366043 hasRelatedWork W2370770133 @default.
• W2020366043 hasRelatedWork W2392007554 @default.
• W2020366043 hasRelatedWork W2559639759 @default.
• W2020366043 hasRelatedWork W2621291586 @default.
• W2020366043 hasRelatedWork W3019703856 @default.
• W2020366043 hasRelatedWork W2968484495 @default.
• W2020366043 hasVolume "7" @default.
• W2020366043 isParatext "false" @default.
• W2020366043 isRetracted "false" @default.
• W2020366043 magId "2020366043" @default.
• W2020366043 workType "article" @default.